focus -WSS

focus

author：explore 2025-09-30 17:59:16 - browse：8

A new treatment for Alzheimer’s disease developed by Eli Lilly slowed patients’ rate of cognitive and functional decline by 35% compared to placebo, the company said Wednesday, paving the way for a submission to the Food and Drug Administration and boosting hopes for a new class of Alzheimer’s drugs.

But the positive outcome of the study involving the drug, called donanemab, could be tempered by the deaths of two patients, and possibly a third, from a type of brain swelling caused by these drugs.

The results of the study were reported in a press release and have not yet been reviewed by outside scientists. Lilly said the data will be used to file for full approval with the FDA before the end of June. If cleared, donanemab will compete with another new Alzheimer’s treatment, Leqembi, made by Eisai and Biogen, that secured FDA approval in January.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Physician groups backed by private equity giant lobby on mergers

leisure time

WSS

The Jan. 6 committee previously recommended Trump be criminally charged. Here's why

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

Trader Joe's recalls 10K cases of broccoli cheddar soup over potential foreign material

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

Sage hopes for a blockbuster in antidepressant now before FDA

Vertex non

hotspot

focus

hotspot

The high cost of giving birth even with insurance

Physician groups backed by private equity giant lobby on mergers

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

Sports medicine is finally prioritizing gender equality

The mammogram wars are not over

The high cost of giving birth even with insurance

The Jan. 6 committee previously recommended Trump be criminally charged. Here's why

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

What the US credit downgrade means for the economy, your finances

focus

Trump allegedly attempted to have surveillance video deleted: Special Counsel

The mammogram wars are not over

Trump allegedly attempted to have surveillance video deleted: Special Counsel

Public health communication lessons from Covid

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Will biotech layoffs continue through 2023?

entertainment

leisure time

leisure time

focus